Drug Shortage Report for AURO-DARUNAVIR
Report ID | 159414 |
Drug Identification Number | 02486148 |
Brand name | AURO-DARUNAVIR |
Common or Proper name | DARUNAVIR |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | DARUNAVIR |
Strength(s) | 800MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30's |
ATC code | J05AE |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-04-26 |
Estimated end date | 2022-07-06 |
Actual end date | 2022-06-30 |
Shortage status | Resolved |
Updated date | 2022-07-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2022-07-04 | French | Compare |
v10 | 2022-07-04 | English | Compare |
v9 | 2022-06-29 | French | Compare |
v8 | 2022-06-29 | English | Compare |
v7 | 2022-06-29 | French | Compare |
v6 | 2022-06-29 | English | Compare |
v5 | 2022-05-30 | French | Compare |
v4 | 2022-05-30 | English | Compare |
v3 | 2022-04-27 | English | Compare |
v2 | 2022-04-26 | French | Compare |
v1 | 2022-04-26 | English | Compare |
Showing 1 to 11 of 11